Hypertelmi Tablet 80mg (Telmisartan)

Adult dose

For the treatment of essential hypertension, Telmisartan is administered orally once daily at a dose of 40 mg with water, and can be taken regardless of meals. It may be effective at a dose of 20 mg once daily depending on the patient. If necessary, the dose may be increased up to 80 mg once daily, with the maximum blood pressure-lowering effect observed 4 to 8 weeks after starting treatment. To reduce the risk of cardiovascular disease, it is recommended to take 80 mg once daily with water.

This medication may cause serious harm, especially to the fetus and newborn during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used by individuals with known allergies to this drug or any of its components, pregnant or breastfeeding women, patients with severe liver disease, those with a history of hereditary angioedema, and patients with certain kidney diseases. Elderly patients, those with hyperkalemia, liver disease, and heart disease should take this medication with caution, as there is a risk of excessively low blood pressure or worsening kidney function. This drug may cause various side effects such as infections, blood abnormalities, allergic reactions, hyperkalemia, hypoglycemia, neurological symptoms, irregular heartbeats, low blood pressure, dyspnea, gastrointestinal issues, liver dysfunction, skin rashes, myalgia, and kidney impairment. In particular, serious adverse reactions such as angioedema or acute renal failure, interstitial pneumonia, and rhabdomyolysis may occur, so patients should consult healthcare professionals immediately if symptoms arise. Kidney function and serum electrolyte levels should be monitored regularly while taking this medication, and if blood pressure drops too low, the patient should be reclined and intravenous therapy should be considered if necessary. Interactions can occur when taken in conjunction with other antihypertensives or certain medications, so it is essential to inform the doctor or pharmacist of any other medications being taken. Women who are pregnant or planning to become pregnant should not take this medication, and breastfeeding women are also advised to avoid it. Safety and efficacy in children and adolescents have not been established, so it is not recommended for this age group. In case of overdose, symptoms such as low blood pressure, dizziness, and acute renal failure may appear, so immediate contact with healthcare professionals and proper treatment is necessary. This medication should be stored out of reach of children, and it is safest to open the package just before use.

Serious side effects

Urticaria, severe swelling (including angioedema and facial edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, severe skin adverse reactions, dyspnea, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice of skin or eyes, extreme lethargy, liver abnormalities, sudden and very severe headache, and tremors

Mild side effects

• Upper respiratory infections
• pharyngitis
• sinusitis
• urinary tract infections
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hypoglycemia

This medication may be sensitive to air or moisture, so it should be stored in a sealed container. The recommended storage temperature is room temperature between 1 degree and 30 degrees Celsius. This will help maintain the effectiveness and safety of the medication.

Appearance

White or nearly white, double-convex round tablets

Package unit

30 tablets/blister [10 tablets/blister × 3]